CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • October 19th, 2015 • Cempra, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 19th, 2015 Company IndustryThis Change in Control Severance Agreement (the “Agreement”) is made as of October 13, 2015, by and between Cempra, Inc., a Delaware corporation with its principal executive offices at 6320 Quadrangle Drive, Suite 360, Chapel Hill, NC 27517 (the “Company”), and David W. Oldach, M.D. (the “Employee”).
FIRST AMENDMENT TO CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • October 19th, 2015 • Cempra, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 19th, 2015 Company IndustryTHIS FIRST AMENDMENT TO CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Amendment”) is made and entered into this 13th day of October, 2015 by and between Cempra, Inc., a Delaware corporation with its principal executive offices at 6320 Quadrangle Drive, Suite 360, Chapel Hill, NC 27517 (the “Company”), and Mark W. Hahn (the “Employee”).
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • October 19th, 2015 • Cempra, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledOctober 19th, 2015 Company Industry JurisdictionTHIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is made and entered into this 13th day of October, 2015 by and between Cempra, Inc., a Delaware corporation with its principal executive offices at 6320 Quadrangle Drive, Suite 360, Chapel Hill, NC 27517 (the “Company”), and Prabhavathi Fernandes, Ph.D. (the “Executive”).
FIRST AMENDMENT TO CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • October 19th, 2015 • Cempra, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledOctober 19th, 2015 Company Industry JurisdictionTHIS FIRST AMENDMENT TO CHANGE IN CONTROL SEVERANCE AGREEMENT (this “Amendment”) is made and entered into this 13th day of October, 2015 by and between Cempra, Inc., a Delaware corporation with its principal executive offices at 6320 Quadrangle Drive, Suite 360, Chapel Hill, NC 27517 (the “Company”), and Prabhavathi Fernandes, Ph.D. (the “Employee”).